叶酸功能化纳米平台共递送PTX/DOX用于体外抗三阴性乳腺癌研究OA
Folic acid-functionalized nanoplatform for co-delivery of PTX/DOX:an in vitro study on triple-negative breast cancer
目的 构建一种叶酸(FA)修饰的普鲁兰多糖(PUL)纳米共递送平台(P/D NP),该平台具有主动靶向及pH敏感缓控释特性,旨在解决紫杉醇(PTX)与多柔比星(DOX)联合化疗中肿瘤靶向性不足、联合递送效率低的问题,为三阴性乳腺癌(TNBC)的精准治疗提供新策略.方法 通过分步酯化与酰胺化反应合成叶酸-普鲁兰多糖-紫杉醇两亲性前药聚合物(FA-PUL-PTX),并采用自组装包载DOX构建P/D NPs.采用傅里叶变换红外光谱验证化学结构;动态光散射与透射电子显微镜表征其粒径、Zeta电位及形貌,并计算载药量与包封率;透析法比较其在pH 7.4与pH 5.5两种释放介质中的体外释放行为.通过倒置荧光显微镜观察MDA-MB-231细胞对叶酸修饰与非修饰纳米粒的摄取差异;通过MTT法、细胞划痕实验及AO/EB染色分别评价其细胞毒性、迁移及凋亡情况.结果 通过优化配方比例,确定最优比(FA-PUL-PTX∶DOX)为1∶1.0,其粒径为(220.12±21.28)nm,多分散指数(PDI)为(0.192±0.014),电位为(-29.18±3.14)mV,形貌规则,近似亚球形.PTX和DOX载药量分别为(7.88±1.03)%和(1.27±0.73)%,包封率分别为(80.01±4.59)%和(7.37±0.98)%.P/D NPs具有明显缓释特性,pH 5.5条件下的48 h累积释放率高于pH 7.4.体外实验表明,叶酸修饰可显著增强MDA-MB-231细胞对纳米粒的摄取.与游离药物组相比,P/D NPs可有效抑制细胞增殖、迁移并诱导细胞凋亡(P<0.05).结论 本研究制备的叶酸功能化P/D NPs粒径均一、分散性良好,具有pH敏感释药性能,可被MDA-MB-231细胞有效摄取,并在体外细胞模型中显示出较游离药物联用方案更强的抗肿瘤活性.
Objective To develop a folic acid(FA)-modified pullulan(PUL)-based nano co-delivery platform(P/D NP)with active targeting and pH-sensitive sustained-release properties,aiming to overcome poor tumor targeting and low co-delivery efficiency associated with paclitaxel(PTX)and doxorubicin(DOX)combination chemotherapy,and to provide a new strategy for precision treatment of triple-negative breast cancer(TNBC).Methods An amphiphilic prodrug conjugate(FA-PUL-PTX)was synthesized through sequential esterification and amidation reactions,followed by self-assembly with DOX to form the co-delivery nanoparticles(P/D NPs).The chemical structure was confirmed by Fourier transform infrared spectroscopy.Particle size,zeta potential,and morphology were characterized using dynamic light scattering and transmis-sion electron microscopy.Drug loading contents and encapsulation efficiencies were calculated.In vitro release profiles were evaluated by dialysis at pH 7.4 and pH 5.5.Cellular uptake of FA-modified versus unmodified nanoparticles was ob-served under an inverted fluorescence microscope.Cytotoxicity,cell migration,and apoptosis were assessed by MTT assay,scratch wound healing assay,and acridine orange/ethidium bromide(AO/EB)staining,respectively.Results The optimal mass ratio of FA-PUL-PTX to DOX was determined to be 1:1.0.The obtained P/D NPs exhibited a uniform size of(220.12±21.28)nm,a polydispersity index of(0.192±0.014),a zeta potential of(-29.18±3.14)mV,and a regular spherical morphology.The drug loading amounts for PTX and DOX were(7.88±1.03)%and(1.27±0.73)%,and the encapsulation effi-ciencies were(80.01±4.59)%and(7.37±0.98)%,respectively.The P/D NPs showed pronounced sustained release behavior,with higher cumulative release at pH 5.5 than at pH 7.4 over 48 h.FA modification significantly enhanced the uptake of nanoparticles by MDA-MB-231 cells.Compared with the free drug combination,P/D NPs more effectively inhibited cell proliferation and migration and induced apoptosis(P<0.05).Conclusion The prepared FA-functionalized nano co-delivery platform(P/D NPs)possesses uniform particle size,good dispersibility,and pH-sensitive drug release performance.It was effectively taken up by MDA-MB-231 cells and exhibited stronger antitumor activity than the free drug combination in vi-tro.
阳亚玲;邓浩;谭玥;彭星诚;袁立明;王志辉;陶晓军
湖南师范大学 医学部,湖南 长沙,410013湖南师范大学 医学部,湖南 长沙,410013湖南师范大学 医学部,湖南 长沙,410013湖南师范大学 医学部,湖南 长沙,410013湖南师范大学 医学部,湖南 长沙,410013长沙卫生职业学院,湖南 长沙,410605湖南师范大学 医学部,湖南 长沙,410013
医药卫生
三阴性乳腺癌紫杉醇叶酸普鲁兰多糖多柔比星纳米共递送靶向治疗
Triple-negative breast cancerPaclitaxelFolic acidPullulanDoxorubicinNano co-deliveryTargeted therapy
《肿瘤药学》 2026 (3)
320-329,10
教育部供需对接就业育人项目(2024080388329)国家级大学生创新创业训练计划支持项目(202510542022).
评论